These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 19499987)
1. Prophylactic thyroidectomy in RET carriers at risk for hereditary medullary thyroid cancer. Machens A; Dralle H Thyroid; 2009 Jun; 19(6):551-4. PubMed ID: 19499987 [No Abstract] [Full Text] [Related]
2. Invited commentary: medullary thyroid cancer: the importance of RET testing. Evans DB; Shapiro SE; Cote GJ Surgery; 2007 Jan; 141(1):96-9. PubMed ID: 17188173 [No Abstract] [Full Text] [Related]
3. Very early manifestation of hereditary medullary thyroid cancer in carriers of intracellular-domain RET mutations. Machens A; Dralle H J Pediatr Surg; 2007 Jun; 42(6):1153; author reply 1154. PubMed ID: 17560241 [No Abstract] [Full Text] [Related]
4. Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2. Moore SW; Appfelstaedt J; Zaahl MG J Pediatr Surg; 2007 Feb; 42(2):326-32. PubMed ID: 17270543 [TBL] [Abstract][Full Text] [Related]
5. [Prophylactic thyroidectomy in children at risk for medullary thyroid carcinoma]. Torres de Aguirre A; Martínez Carol A; Cabello Laureano R; García Valles C; Gómez Gila A; del Valle Núñez J Cir Pediatr; 2005 Jul; 18(3):106-8. PubMed ID: 16209369 [TBL] [Abstract][Full Text] [Related]
6. DNA-based window of opportunity for curative pre-emptive therapy of hereditary medullary thyroid cancer. Machens A; Dralle H Surgery; 2006 Mar; 139(3):279-82. PubMed ID: 16546489 [No Abstract] [Full Text] [Related]
7. [Prophylactic thyroidectomy in children who are carriers of a multiple endocrine neoplasia type 2 mutation: description of 20 cases and recommendations based on the literature]. de Groot JW; Links TP; Rouwe CW; van der Wal JE; Hofstra RM; Plukker JT Ned Tijdschr Geneeskd; 2006 Feb; 150(6):311-8. PubMed ID: 16503023 [TBL] [Abstract][Full Text] [Related]
8. Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotype. Frank-Raue K; Buhr H; Dralle H; Klar E; Senninger N; Weber T; Rondot S; Höppner W; Raue F Eur J Endocrinol; 2006 Aug; 155(2):229-36. PubMed ID: 16868135 [TBL] [Abstract][Full Text] [Related]
9. Preventive thyroidectomy in patients with hereditary medullary thyroid carcinoma found heterozygote for mutant RET proto-oncogene. Konstantinou E; Sapsakos Mariolis T; Fotis T; Mitsos A; Restos S; Mamoura K; Soultati A; Elefsiniotis I; Kapellakis G Pediatr Endocrinol Rev; 2010 Dec; 8(2):108-13. PubMed ID: 21150841 [TBL] [Abstract][Full Text] [Related]
10. New presentation of familial medullary thyroid carcinoma in 87-year-old patient with high-risk RET proto-oncogene codon 620 mutation. Jaggard MK; MacRae C; Ifeacho S; Robinson S; Tolley NS J Laryngol Otol; 2009 Jul; 123(7):796-800. PubMed ID: 18771606 [TBL] [Abstract][Full Text] [Related]
11. [Tumor dormancy of hereditary medullary thyroid carcinoma and RET gene mutations]. Yü Y; Gao M; Zhang F Zhonghua Zhong Liu Za Zhi; 2008 Jul; 30(7):532-3. PubMed ID: 19062722 [No Abstract] [Full Text] [Related]
12. Role of RET codonic mutations in the surgical management of medullary thyroid carcinoma in pediatric age multiple endocrine neoplasm type 2 syndromes. Spinelli C; Di Giacomo M; Costanzo S; Elisei R; Miccoli P J Pediatr Surg; 2010 Aug; 45(8):1610-6. PubMed ID: 20713208 [TBL] [Abstract][Full Text] [Related]
14. Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations. Learoyd DL; Gosnell J; Elston MS; Saurine TJ; Richardson AL; Delbridge LW; Aglen JV; Robinson BG Clin Endocrinol (Oxf); 2005 Dec; 63(6):636-41. PubMed ID: 16343097 [TBL] [Abstract][Full Text] [Related]
15. Prognostic factors of disease-free survival after thyroidectomy in 170 young patients with a RET germline mutation: a multicenter study of the Groupe Francais d'Etude des Tumeurs Endocrines. Rohmer V; Vidal-Trecan G; Bourdelot A; Niccoli P; Murat A; Wemeau JL; Borson-Chazot F; Schvartz C; Tabarin A; Chabre O; Chabrier G; Caron P; Rodien P; Schlumberger M; Baudin E; J Clin Endocrinol Metab; 2011 Mar; 96(3):E509-18. PubMed ID: 21190982 [TBL] [Abstract][Full Text] [Related]
16. [Hirschsprung's disease, RET proto-oncogene mutation and prophylactic thyroidectomy]. Marcacuzco Quinto AA; Martínez Pueyo JI; Gómez Rodríguez P; de la Cruz Vigo F Med Clin (Barc); 2014 Aug; 143(4):185-6. PubMed ID: 24342010 [No Abstract] [Full Text] [Related]
18. Mutation analysis of the RET proto-oncogene and early thyroidectomy: results of a Portuguese cancer centre. Bugalho MJ; Domingues R; Santos JR; Catarino AL; Sobrinho L Surgery; 2007 Jan; 141(1):90-5. PubMed ID: 17188172 [TBL] [Abstract][Full Text] [Related]
19. [Hereditary thyroid cancer can be cured by prophylactic surgery]. Wallin G; Bondesson AG; Farnebo LO; Hallengren B; Hamberger B; Jansson S; Nilsson O; Nordenskjöld M; Smeds S; Svensson KA; Wihlborg O; Zedenius J Lakartidningen; 2001 Jun; 98(25):3024-8. PubMed ID: 11462876 [TBL] [Abstract][Full Text] [Related]